ATE267015T1 - Verbindungen und verfahren zur behandlung von krebs - Google Patents
Verbindungen und verfahren zur behandlung von krebsInfo
- Publication number
- ATE267015T1 ATE267015T1 AT95933071T AT95933071T ATE267015T1 AT E267015 T1 ATE267015 T1 AT E267015T1 AT 95933071 T AT95933071 T AT 95933071T AT 95933071 T AT95933071 T AT 95933071T AT E267015 T1 ATE267015 T1 AT E267015T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- methods
- treating cancer
- cancer
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/301,298 US5817667A (en) | 1991-04-17 | 1994-09-06 | Compounds and methods for the treatment of cancer |
US39063395A | 1995-02-17 | 1995-02-17 | |
PCT/US1995/011464 WO1996007413A1 (en) | 1994-09-06 | 1995-09-05 | Compounds and methods for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE267015T1 true ATE267015T1 (de) | 2004-06-15 |
Family
ID=26972285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95933071T ATE267015T1 (de) | 1994-09-06 | 1995-09-05 | Verbindungen und verfahren zur behandlung von krebs |
Country Status (31)
Country | Link |
---|---|
US (3) | US6063787A (de) |
EP (2) | EP0781136B1 (de) |
JP (1) | JP3979662B2 (de) |
KR (1) | KR100374477B1 (de) |
CN (3) | CN1111409C (de) |
AP (1) | AP783A (de) |
AT (1) | ATE267015T1 (de) |
AU (1) | AU704977B2 (de) |
BG (1) | BG63122B1 (de) |
BR (1) | BR9508886A (de) |
CA (1) | CA2199117C (de) |
CZ (1) | CZ297873B6 (de) |
DE (1) | DE69533066T2 (de) |
DK (1) | DK0781136T3 (de) |
ES (1) | ES2219666T3 (de) |
FI (1) | FI970918A (de) |
HU (1) | HUT77172A (de) |
IL (1) | IL115156A (de) |
IS (1) | IS2011B (de) |
MY (1) | MY121548A (de) |
NO (1) | NO313268B1 (de) |
NZ (1) | NZ335013A (de) |
OA (1) | OA10473A (de) |
PL (2) | PL189288B1 (de) |
PT (1) | PT781136E (de) |
RO (1) | RO118748B1 (de) |
RU (1) | RU2168995C2 (de) |
SI (1) | SI0781136T1 (de) |
SK (1) | SK284564B6 (de) |
WO (1) | WO1996007413A1 (de) |
ZA (1) | ZA957483B (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6903224B2 (en) | 1988-04-11 | 2005-06-07 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes |
US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
IL115156A (en) * | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US6022876A (en) * | 1996-11-15 | 2000-02-08 | Yale University | L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
JP2001512830A (ja) | 1997-08-08 | 2001-08-28 | ニューバイオティックス インコーポレイテッド | 生物療法耐性および化学療法耐性を克服するための方法および組成物 |
ES2172303T3 (es) | 1998-01-23 | 2002-09-16 | Newbiotics Inc | Agentes terapeuticos obtenidos por catalisis enzimatica. |
US7462605B2 (en) | 1998-01-23 | 2008-12-09 | Celmed Oncology (Usa), Inc. | Phosphoramidate compounds and methods of use |
EA008609B1 (ru) | 1998-02-25 | 2007-06-29 | Эмори Юниверсити | 2'-фторнуклеозиды |
AU2004201676B2 (en) * | 1999-03-29 | 2006-03-09 | University Of Georgia Research Foundation, Inc. | Methods of treating leukemia |
CN1297281C (zh) * | 1999-03-29 | 2007-01-31 | 希拉生物化学股份有限公司 | 治疗白血病的方法 |
US6653318B1 (en) | 1999-07-21 | 2003-11-25 | Yale University | 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use |
US6683061B1 (en) | 1999-07-22 | 2004-01-27 | Newbiotics, Inc. | Enzyme catalyzed therapeutic activation |
DE60011637T2 (de) | 1999-09-24 | 2004-11-11 | Shire Biochem Inc., Laval | Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen |
WO2001032153A2 (en) | 1999-11-04 | 2001-05-10 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
EP1600451A3 (de) | 1999-11-12 | 2008-09-10 | Pharmasset, Inc. | Herstellung von 2'-Deoxy-L-Nukleoside |
HUP0301363A2 (hu) * | 2000-10-13 | 2005-12-28 | Shire Biochem Inc. | Javított intercelluláris bejuttathatóságú dioxolán analógok |
WO2002056832A2 (en) | 2001-01-19 | 2002-07-25 | Newbiotics, Inc. | Methods to treat autoimmune and inflammatory conditions |
EP1370270B1 (de) | 2001-03-23 | 2009-12-02 | Shire Canada Inc. | Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält |
CN1744902B (zh) * | 2001-03-23 | 2010-05-26 | 希拉加拿大股份有限公司 | 治疗癌症的药物组合 |
US20030027799A1 (en) * | 2001-03-30 | 2003-02-06 | Shire Biochem Inc. | Methods of treating cancer using a combination of drugs |
CA2465682A1 (en) | 2001-11-02 | 2003-05-08 | Shire Biochem Inc. | Methods of treating leukemia |
ES2319626T3 (es) * | 2001-11-19 | 2009-05-11 | Medigene Ag | Farmaco para el tratamiento de enfermedades tumorales y de la piel virales. |
KR100620185B1 (ko) | 2002-06-21 | 2006-09-01 | 엘지전자 주식회사 | 비디오 데이터의 재생을 관리하기 위한 데이터 구조를갖는 기록 매체 |
MXPA04002365A (es) | 2002-06-21 | 2004-11-22 | Lg Electronics Inc | Medio de grabacion que tiene estructura de datos para manejar la reproduccion de datos de video grabados en el mismo. |
RU2320030C2 (ru) | 2002-06-24 | 2008-03-20 | Эл Джи Электроникс Инк. | Носитель записи со структурой данных для управления воспроизведением записанных на нем видеоданных нескольких каналов воспроизведения и способы и устройства записи и воспроизведения |
KR20040000290A (ko) | 2002-06-24 | 2004-01-03 | 엘지전자 주식회사 | 고밀도 광디스크의 멀티 경로 데이터 스트림 관리방법 |
WO2004003908A1 (en) | 2002-06-28 | 2004-01-08 | Lg Electronics Inc. | Recording medium having data structure for managing recording and reproduction of multiple path data recorded thereon and recording and reproducing methods and apparatus |
CA2469176C (en) | 2002-10-14 | 2010-09-14 | Lg Electronics Inc. | Recording medium having data structure for managing reproduction of multiple audio streams recorded thereon and recording and reproducing methods and apparatuses |
ATE547792T1 (de) | 2002-10-15 | 2012-03-15 | Lg Electronics Inc | Aufzeichnungsmedium mit einer datenstruktur zur verwaltung der wiedergabe mehrerer darauf aufgezeichneter grafikströme und aufzeichnungs- und wiedergabeverfahren und vorrichtungen |
US7720356B2 (en) | 2002-11-12 | 2010-05-18 | Lg Electronics Inc | Recording medium having data structure for managing reproduction of multiple reproduction path video data recorded thereon and recording and reproducing methods and apparatuses |
US7664372B2 (en) | 2002-11-20 | 2010-02-16 | Lg Electronics Inc. | Recording medium having data structure for managing reproduction of multiple component data recorded thereon and recording and reproducing methods and apparatuses |
US7693394B2 (en) | 2003-02-26 | 2010-04-06 | Lg Electronics Inc. | Recording medium having data structure for managing reproduction of data streams recorded thereon and recording and reproducing methods and apparatuses |
US7809775B2 (en) | 2003-02-27 | 2010-10-05 | Lg Electronics, Inc. | Recording medium having data structure for managing playback control recorded thereon and recording and reproducing methods and apparatuses |
WO2004077417A1 (en) | 2003-02-28 | 2004-09-10 | Lg Electronics Inc. | Recording medium having data structure for managing random/shuffle reproduction of video data recorded thereon and recording and reproducing methods and apparatuses |
US7620301B2 (en) | 2003-04-04 | 2009-11-17 | Lg Electronics Inc. | System and method for resuming playback |
RU2366447C2 (ru) | 2003-10-09 | 2009-09-10 | Медигене Аг | Лекарственное средство для лечения предраковых поражений кожи |
SG162753A1 (en) * | 2005-06-07 | 2010-07-29 | Univ Yale | Methods of treating cancer and other conditions or disease states using lfmau and ldt |
CN101511375B (zh) | 2005-12-02 | 2012-09-05 | 耶鲁大学 | L-胞嘧啶核苷类似物在制备用于治疗癌症和其它病症或疾病状态的药物中的应用 |
NO324263B1 (no) | 2005-12-08 | 2007-09-17 | Clavis Pharma Asa | Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser |
AU2007293377A1 (en) * | 2006-09-01 | 2008-03-13 | University Of Georgia Research Foundation, Inc. | L- OddC prodrugs for cancer |
CN102406649A (zh) * | 2011-11-15 | 2012-04-11 | 张始状 | 人体五种正常碱基在制备治疗肿瘤药物中的应用 |
CN103720693A (zh) * | 2011-11-15 | 2014-04-16 | 张始状 | 人体五种正常碱基在制备治疗肿瘤药物中的应用 |
SG10201609131YA (en) | 2016-11-01 | 2018-06-28 | Xylonix Ip Holdings Pte Ltd | Zinc-pga compositions and methods for treating cancer |
KR20190097240A (ko) * | 2016-12-28 | 2019-08-20 | 트랜스진 에스.에이. | 종양용해성 바이러스 및 치료 분자 |
SG10201708886RA (en) * | 2017-10-30 | 2019-05-30 | Xylonix Ip Holdings Pte Ltd | α-PGA-ZINC COMPOSITIONS AND METHODS FOR TREATING CANCER |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000137A (en) * | 1975-06-10 | 1976-12-28 | American Home Products Corporation | Antitumor derivatives of periodate-oxidized nucleosides |
JPS5668674A (en) * | 1979-11-08 | 1981-06-09 | Shionogi & Co Ltd | 5-fluorouracil derivative |
ATE108794T1 (de) * | 1985-05-15 | 1994-08-15 | Wellcome Found | Therapeutische nucleoside und deren herstellung. |
US4879277A (en) * | 1985-08-26 | 1989-11-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral compositions and methods |
AU570853B2 (en) * | 1985-08-26 | 1988-03-24 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases |
DK167377B1 (da) * | 1985-09-17 | 1993-10-25 | Wellcome Found | 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion |
IN164556B (de) * | 1986-03-06 | 1989-04-08 | Takeda Chemical Industries Ltd | |
US4916122A (en) * | 1987-01-28 | 1990-04-10 | University Of Georgia Research Foundation, Inc. | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
FR2601385B1 (fr) * | 1986-07-09 | 1989-09-29 | Sucre Rech & Dev | Procede de preparation a partir de saccharose d'un melange de sucres a haute teneur en isomaltose par voie enzymatique et produits obtenus |
US4963533A (en) * | 1986-10-24 | 1990-10-16 | Stichting Rega Vzw (Rega) | Therapeutic application of dideoxycytidinene |
US5215971A (en) * | 1986-12-19 | 1993-06-01 | Medivir Ab | Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides |
WO1988007532A1 (en) * | 1987-03-24 | 1988-10-06 | Nycomed A.S. | 2',3' dideoxyribofuranoxide derivatives |
US5185437A (en) * | 1987-04-09 | 1993-02-09 | Burroughs Wellcome Co. | Therapeutic nucleosides |
US5041449A (en) * | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
NZ228645A (en) * | 1988-04-11 | 1991-09-25 | Iaf Biochem Int | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections |
US5270315A (en) * | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US4900828A (en) * | 1988-05-12 | 1990-02-13 | Hoffmann-Laroche Inc. | Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine |
SE8802687D0 (sv) * | 1988-07-20 | 1988-07-20 | Astra Ab | Nucleoside derivatives |
US5043339A (en) * | 1988-12-19 | 1991-08-27 | Burroughs Wellcome Co. | Antiviral compounds |
UA45942A (uk) * | 1989-02-08 | 2002-05-15 | Біокем Фарма, Інк. | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція |
NZ233197A (en) * | 1989-04-13 | 1991-11-26 | Richard Thomas Walker | Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions |
US5059690A (en) * | 1990-03-01 | 1991-10-22 | E. R. Squibb & Sons, Inc. | Purinyl tetrahydrofurans |
US5071983A (en) * | 1989-10-06 | 1991-12-10 | Burroughs Wellcome Co. | Therapeutic nucleosides |
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
IE904378A1 (en) * | 1989-12-20 | 1991-07-03 | Abbott Lab | Analogs of oxetanyl purines and pyrimidines |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US5700937A (en) * | 1990-02-01 | 1997-12-23 | Emory University | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
US5527782A (en) * | 1990-03-13 | 1996-06-18 | Acic (Canada) Inc. | 5-halo-2,3'-O-cyclocytidines |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
WO1992010496A1 (en) * | 1990-12-05 | 1992-06-25 | University Of Georgia Research Foundation, Inc. | ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
US5179104A (en) * | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US5248776A (en) * | 1990-12-05 | 1993-09-28 | University Of Georgia Research Foundation, Inc. | Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides |
IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
IL100965A (en) * | 1991-02-22 | 1999-12-31 | Univ Emory | 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it |
AU662130B2 (en) * | 1991-03-06 | 1995-08-24 | Emory University | Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis B |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
WO1992018517A1 (en) * | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
GB9111902D0 (en) * | 1991-06-03 | 1991-07-24 | Glaxo Group Ltd | Chemical compounds |
GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
GB9226927D0 (en) | 1992-12-24 | 1993-02-17 | Iaf Biochem Int | Dideoxy nucleoside analogues |
US5627160A (en) * | 1993-05-25 | 1997-05-06 | Yale University | L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
US5811538A (en) * | 1993-12-30 | 1998-09-22 | Genta, Incorporated | Process for the purification of oligomers |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL115156A (en) * | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US5971983A (en) * | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
-
1995
- 1995-09-04 IL IL11515695A patent/IL115156A/xx not_active IP Right Cessation
- 1995-09-05 DE DE69533066T patent/DE69533066T2/de not_active Expired - Lifetime
- 1995-09-05 PT PT95933071T patent/PT781136E/pt unknown
- 1995-09-05 PL PL95358979A patent/PL189288B1/pl not_active IP Right Cessation
- 1995-09-05 WO PCT/US1995/011464 patent/WO1996007413A1/en active IP Right Grant
- 1995-09-05 CZ CZ0063397A patent/CZ297873B6/cs not_active IP Right Cessation
- 1995-09-05 JP JP50970596A patent/JP3979662B2/ja not_active Expired - Lifetime
- 1995-09-05 AP APAP/P/1997/000939A patent/AP783A/en active
- 1995-09-05 CA CA002199117A patent/CA2199117C/en not_active Expired - Fee Related
- 1995-09-05 CN CN95195621A patent/CN1111409C/zh not_active Expired - Lifetime
- 1995-09-05 KR KR1019970701464A patent/KR100374477B1/ko not_active IP Right Cessation
- 1995-09-05 AT AT95933071T patent/ATE267015T1/de not_active IP Right Cessation
- 1995-09-05 AU AU35862/95A patent/AU704977B2/en not_active Ceased
- 1995-09-05 RO RO97-00419A patent/RO118748B1/ro unknown
- 1995-09-05 SK SK281-97A patent/SK284564B6/sk not_active IP Right Cessation
- 1995-09-05 HU HU9701687A patent/HUT77172A/hu unknown
- 1995-09-05 SI SI9530703T patent/SI0781136T1/xx unknown
- 1995-09-05 RU RU97105381/04A patent/RU2168995C2/ru not_active IP Right Cessation
- 1995-09-05 CN CNA2006100549917A patent/CN1827108A/zh active Pending
- 1995-09-05 EP EP95933071A patent/EP0781136B1/de not_active Expired - Lifetime
- 1995-09-05 DK DK95933071T patent/DK0781136T3/da active
- 1995-09-05 EP EP04003357A patent/EP1468687A1/de not_active Withdrawn
- 1995-09-05 PL PL95318971A patent/PL188359B1/pl not_active IP Right Cessation
- 1995-09-05 ES ES95933071T patent/ES2219666T3/es not_active Expired - Lifetime
- 1995-09-05 US US08/809,007 patent/US6063787A/en not_active Expired - Fee Related
- 1995-09-05 BR BR9508886A patent/BR9508886A/pt not_active Application Discontinuation
- 1995-09-06 MY MYPI95002637A patent/MY121548A/en unknown
- 1995-09-06 ZA ZA957483A patent/ZA957483B/xx unknown
-
1997
- 1997-03-03 OA OA60972A patent/OA10473A/en unknown
- 1997-03-04 IS IS4434A patent/IS2011B/is unknown
- 1997-03-04 FI FI970918A patent/FI970918A/fi unknown
- 1997-03-05 NO NO19971015A patent/NO313268B1/no not_active IP Right Cessation
- 1997-03-05 BG BG101284A patent/BG63122B1/xx unknown
-
1999
- 1999-04-01 NZ NZ335013A patent/NZ335013A/xx not_active IP Right Cessation
-
2003
- 2003-04-18 CN CNB031106706A patent/CN1251680C/zh not_active Expired - Lifetime
- 2003-08-22 US US10/646,980 patent/US7262213B2/en not_active Expired - Lifetime
-
2007
- 2007-03-05 US US11/713,975 patent/US8076347B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE267015T1 (de) | Verbindungen und verfahren zur behandlung von krebs | |
ATE230606T1 (de) | Verfahren zur vorbeugung und behandlung von allergien | |
DE69425372T2 (de) | Verfahren zur behandlung endo-ostealer materialien | |
DE69331469T2 (de) | Verfahren zur behandlung von abfällen | |
DE69730604D1 (de) | Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen | |
ATE477270T1 (de) | Verfahren und zusammensetzungen zur prävention und behandlung von anämie | |
DE69925266D1 (de) | Verfahren und gerät zur behandlung von herzarhythmie | |
DE69112480T2 (de) | Verfahren und Vorrichtung zur Behandlung von medizinischen Abfallstoffen. | |
DE69816070D1 (de) | Verfahren zur Behandlung von Schredderstaub | |
DE69714828D1 (de) | Verfahren zur Behandlung von Abfallstoffen | |
DE69426485D1 (de) | Verfahren und System zur Behandlung von verunreinigtem Wasser | |
DE69417018D1 (de) | Verfahren zur behandlung von teilchenmaterial | |
DE69600480T2 (de) | Verfahren und vorrichtung zur behandlung von aggregat | |
DE69518824D1 (de) | Verfahren zur behandlung von bremsscheiben | |
DE69702997D1 (de) | Verfahren zur Behandlung von verunreinigtem Aluminiumoxid | |
DE69328615D1 (de) | Verfahren zur behandlung von viehhaltungsgülle | |
DE69607559T2 (de) | Verfahren zur Behandlung von Phenolteer | |
DE69706758T2 (de) | Verfahren zur Behandlung von Polyolefin | |
DE59308384D1 (de) | Verfahren zur Behandlung von Gülle | |
DE69510990T2 (de) | Verfahren und Vorrichtung zur Behandlung von metallichem Material | |
DE69935858D1 (de) | Verfahren und vorrichtung zur behandlung von scheiben | |
DE69535154D1 (de) | Verfahren zur Behandlung von Textilmaterialien | |
DE69913051D1 (de) | Verfahren zur Behandlung und Entsorgung von einer Epithio-Verbindung | |
ATE222217T1 (de) | Verfahren und einrichtung zur behandlung von fluiden | |
DE69427897D1 (de) | Verfahren zur Behandlung von kontaminierten Sedimenten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0781136 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |